New study tests best fasting time for GLP-1 users
NCT ID NCT07225816
First seen Nov 11, 2025 · Last updated May 01, 2026 · Updated 23 times
Summary
This study looks at how long people with obesity should fast and pause their GLP-1 medications (liraglutide or semaglutide) to ensure their stomach is empty after a high-fat meal. Researchers will measure stomach contents using ultrasound in 75 adults already taking these drugs. The goal is to improve safety for procedures requiring an empty stomach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Altasciences Clinical LA, Inc.
RECRUITINGCypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.